Massive Vaccine Joint Venture With Canada's Microbix Will Help China Prepare Defense Arsenal Against Viral Threats Of The Future
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The head of Canada's Microbix Biosystems said the biologics firm is set to help transform China into a global power in terms of vaccine production, in an equally co-owned joint venture with a government-owned outfit in the heart of the rapidly rising country
You may also be interested in...
Chinese Drug Regulators Issue New Rules To Increase Safety Standards Of Vaccines
BEIJING - In the wake of a series of vaccine scandals across China during the past year, triggering sometimes fatal adverse events, China's State FDA is strengthening rules governing the manufacturing, distribution and inspection of vaccines nationwide
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).